The World According to Boyar

The World According to Boyar - Episode 11 - Kenneth L. Davis, MD

November 19, 2019 The Boyar Value Group
The World According to Boyar
The World According to Boyar - Episode 11 - Kenneth L. Davis, MD
Chapters
The World According to Boyar
The World According to Boyar - Episode 11 - Kenneth L. Davis, MD
Nov 19, 2019
The Boyar Value Group

Kenneth L. Davis, MD, President and Chief Executive Officer of the Mount Sinai Health System, is widely recognized as a visionary leader who has guided the institution on a strong and dramatic growth trajectory. In 2013, the Mount Sinai Health System was formed by the combination of The Mount Sinai Medical Center and Continuum Health Partners, becoming one of the largest nonprofit systems in the country with $8 billion in revenue, 42,000 employees, eight hospitals, and more than 410 ambulatory practices throughout the five boroughs of New York City, Westchester, Long Island, and Florida. Prior to becoming CEO, Dr. Davis spent 15 years as Chair of Mount Sinai’s Department of Psychiatry. He was the first Director for many of the institution’s research entities, including Mount Sinai’s National Institutes of Health (NIH)-funded Alzheimer’s Disease Research Center, the Schizophrenia Biological Research Center at the Bronx Veterans Affairs Medical Center, the Silvio Conte Neuroscience Center to study schizophrenia, and the Seaver Autism Center for Research and Treatment. Additionally, he received one of the first and largest program project grants for Alzheimer’s disease research from the NIH.

The interview discusses:

● How Dr. Davis led one of the greatest financial turnarounds in medical history;

● The reasons why healthcare keeps becoming more expensive along with solutions on how to decrease costs without sacrificing care;
 
 ● Why drug pricing should be a trade issue;
 
 ● Why the current patent system discourages pharmaceutical innovation;
 
 ● What “value based” medicine is and why insurance companies and hospitals should consider adopting it;
 
 ● Why the National Institutes of Health is so vital to drug discovery;
 
 ● His thoughts on CVS’s strategy of becoming an integrated health care provider;
 
 ● What serious healthcare problem he sees getting worse which he believes has the potential to bankrupt the entire Medicare system;

And much more….

Show Notes

Kenneth L. Davis, MD, President and Chief Executive Officer of the Mount Sinai Health System, is widely recognized as a visionary leader who has guided the institution on a strong and dramatic growth trajectory. In 2013, the Mount Sinai Health System was formed by the combination of The Mount Sinai Medical Center and Continuum Health Partners, becoming one of the largest nonprofit systems in the country with $8 billion in revenue, 42,000 employees, eight hospitals, and more than 410 ambulatory practices throughout the five boroughs of New York City, Westchester, Long Island, and Florida. Prior to becoming CEO, Dr. Davis spent 15 years as Chair of Mount Sinai’s Department of Psychiatry. He was the first Director for many of the institution’s research entities, including Mount Sinai’s National Institutes of Health (NIH)-funded Alzheimer’s Disease Research Center, the Schizophrenia Biological Research Center at the Bronx Veterans Affairs Medical Center, the Silvio Conte Neuroscience Center to study schizophrenia, and the Seaver Autism Center for Research and Treatment. Additionally, he received one of the first and largest program project grants for Alzheimer’s disease research from the NIH.

The interview discusses:

● How Dr. Davis led one of the greatest financial turnarounds in medical history;

● The reasons why healthcare keeps becoming more expensive along with solutions on how to decrease costs without sacrificing care;
 
 ● Why drug pricing should be a trade issue;
 
 ● Why the current patent system discourages pharmaceutical innovation;
 
 ● What “value based” medicine is and why insurance companies and hospitals should consider adopting it;
 
 ● Why the National Institutes of Health is so vital to drug discovery;
 
 ● His thoughts on CVS’s strategy of becoming an integrated health care provider;
 
 ● What serious healthcare problem he sees getting worse which he believes has the potential to bankrupt the entire Medicare system;

And much more….